RYBELSUS 3 MG

What is Rybelsus 3mg (Semaglutide)?

Rybelsus 3mg is a once-daily oral tablet that contains Semaglutide, a GLP-1 receptor agonist used to initiate treatment for type 2 diabetes mellitus. Manufactured by Novo Nordisk, Rybelsus 3mg is the initial starting dose, designed to help your body adjust to Semaglutide and reduce potential side effects like nausea before increasing to higher therapeutic doses like 7mg or 14mg.

Unlike injectable GLP-1 drugs such as Ozempic, Rybelsus is the first GLP-1 receptor agonist available in tablet form, offering a needle-free alternative for blood sugar management.

Primary Uses of Rybelsus 3mg:

• Initiation of Semaglutide therapy in adults with type 2 diabetes

• Helps the body adjust to GLP-1 medication to minimize side effects

• Supports future escalation to 7mg or 14mg for improved glycemic control

• Indirectly aids in early appetite suppression and slight weight reduction

Note: Rybelsus 3mg is not a therapeutic dose and should not be used long-term for blood sugar control or weight loss.

How Does Rybelsus Work?

Rybelsus mimics the GLP-1 hormone, which regulates blood sugar and appetite. Even at the 3mg dose, it begins working by:

• Stimulating insulin production in response to high blood sugar

• Reducing glucagon secretion to prevent excess sugar release

• Slowing gastric emptying, increasing feelings of fullness

• Starting to suppress appetite, preparing the body for higher doses

Who Should Use Rybelsus 3mg?

• Adults with type 2 diabetes starting on Semaglutide therapy

• Patients new to GLP-1 receptor agonists

• People preferring a needle-free, oral medication

• Individuals preparing for 7mg or 14mg Rybelsus treatment

Who Should Avoid It?

• Patients with type 1 diabetes

• Individuals with a history of thyroid cancer (MTC) or MEN 2

• Children under 18

• Pregnant or breastfeeding women

• Patients already on GLP-1 injectables (e.g., Ozempic, Wegovy)

Dosage & Administration:

• Dose: 3mg once daily for 30 days only

• After 30 days, increase to 7mg once daily

• May be increased to 14mg if additional control is needed

✅ How to Take Rybelsus:

• Take in the morning on an empty stomach

• Swallow tablet whole with no more than 4 oz (120 mL) of plain water

• Wait at least 30 minutes before eating, drinking (other than water), or taking other medications

• Do not crush, split, or chew the tablet

Expected Results (at 3mg):

• Mild appetite suppression

• Minimal HbA1c improvement

• Body begins to adjust to Semaglutide

• Side effects like nausea are minimized for better tolerance to higher doses

Common Side Effects:

• Nausea (usually mild)

• Diarrhea or constipation

• Loss of appetite

• Abdominal discomfort

• Fatigue

Serious Side Effects (Seek Immediate Help):

• Severe stomach pain (possible pancreatitis)

• Signs of thyroid tumors (neck lump, hoarseness)

• Vision changes (especially with diabetic retinopathy)

• Allergic reactions (swelling, itching, difficulty breathing)

Precautions:

• Use only as a starter dose; do not continue at 3mg beyond 30 days unless advised

• Monitor blood sugar regularly

• Inform your doctor of any gastrointestinal or thyroid conditions

• Avoid use with other GLP-1 medications

Drug Interactions:

Rybelsus may delay absorption of oral medications due to slower stomach emptying. Be cautious with:

• Oral contraceptives

• Levothyroxine

• Warfarin or blood thinners

• Antibiotics

• Insulin or sulfonylureas (increased hypoglycemia risk)

Storage Instructions:

• Store in the original blister pack

• Keep at 15–30°C (59–86°F)

• Protect from moisture, heat, and direct sunlight

• Do not use if the packaging is damaged or expired